share_log

HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $144 Price Target

HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $144 Price Target

HC Wainwright & Co.重申买入Ligand Pharmicals,维持144美元的目标股价
Benzinga ·  05/08 06:33

HC Wainwright & Co. analyst Joseph Pantginis reiterates Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy and maintains $144 price target.

HC Wainwright & Co. 分析师约瑟夫·潘吉尼斯重申了Ligand Pharmicals(纳斯达克股票代码:LGND)的买入并维持144美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发